WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 21-Sep-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 43'4901 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 50'7161 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 82'114  81'915  81'708  81'490  81'265  81'488  79'118  78'301 
Births 725  718  711  703  696  749  830  814 
Surviving infants 723  716  709  701  694  746  824  804 
Pop. less than 5 years 3'595  3'557  3'518  3'480  3'446  3'920  4'358  3'966 
Pop. less than 15 years 10'736  10'722  10'719  10'730  10'762  12'779  12'637  14'552 
Female 15-49 years 17'173  17'357  17'536  17'719  17'888  19'536  19'393  19'240 

Number of reported cases

(Click for retrospective incidence data for Germany)
Diphtheria
ChartChart
  11  14  19 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  929  326  2'464  443  1'771  28'745 
Mumps
ChartChart
  652  741  699  837 
Pertussis
ChartChart
  16'183  13'809  9'000  12'260  258 
Polio*
ChartChart
 
Rubella
ChartChart
  74  95  90  151 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  18  21 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Germany)
Vaccine year result method % card seen                                                
BCG         
DTP1          99  99  99  99  99 
DTP3          96  78  80 
DTP4          95  95  96  96 
IPV1          98  98  99  99 
HepB_BD         
HepB3          87  88  88  88  87  45 
Hib3          93  93  94  94  94  82 
JapEnc         
MCV1          97  97  97  97  97  92  50 
MCV2          93  93  93  93  92 
MenA         
PCV1          89  88 
PCV2         
PCV3          84  86  85  85  68 
Pol3          94  95  95  95  95  95  85 
Rota1          79  78  78 
RotaC          68  67 
RCV1          97  97  97  96  96 
TT2plus          80 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Germany)
DTP1
ChartChart
  99  99  99  99  99  96  93 
DTP3
ChartChart
  95  95  95  95  95  90  80 
HepB3
ChartChart
  87  87  87  87  87  84 
HepB_BD
 
Hib3
ChartChart
  93  93  93  93  93  94 
MCV1
ChartChart
  97  97  97  97  97  92  75  25 
MCV2
ChartChart
  93  93  93  93  93 
PCV3
ChartChart
  84  84  84  84  84 
Pol3
  94  94  94  94  94  94  80  80 
RCV1
ChartChart
  97  97  97  97  97  92 
RotaC
ChartChart
  68  68  68  67 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 402  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaP 2, 3, 4, 11-14 months; Yes
DTaPHibHepBIPV 2, 3, 4, 11-14 months; Yes
DTaPHibHepIPV 2, 3, 4, 11-14 months; Yes
DTaPHibIPV 2, 3, 4, 11-14 months; Yes
DTaPIPV 9-17 years; Yes
HepB_Pediatric 2, 4, 11-14 months; Yes
HPV 9-14 years (x2); Yes females (catch-up 14-17 years)
Influenza_Adult >=60 years; Yes and adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities, Haj or other travellers, other risk groups
Influenza_Pediatric Yes children with chronic illness
MenC_conj 11-23 months; Yes
MMR 11-14, 15-23 months; Yes and adults born after 1970
MMRV 15-23 months; Yes
Pneumo_conj 2, 4, 11-14 months; Yes
Pneumo_ps >=60 years; Yes
Rotavirus 6, 10, 14 weeks; Yes 3rd dose depending on vaccine presentation
Tdap Yes every 10 years
TdaPIPV 5-7, 9-17 years; Yes
Varicella 11-14, 15-23 months; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 402  402  402  402  402  402  412 
Nº districts with DTP3 coverage >=80% number              
Nº districts with measles (MCV1) coverage >=95% number 298  308  268         
% of districts with MCV1 coverage >=95% From 0 to 100% 74  77  67         

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  NA  Yes  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%         NA  NA  NA 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.